BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2561735)

  • 41. A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.
    Vance KW; Campo MS; Morgan IM
    J Virol; 2001 Mar; 75(6):2829-38. PubMed ID: 11222708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory action of epiderstatin on EGF-stimulated growth of mouse epidermal. BALB/MK cells without direct effect on protein kinase activities.
    Osada H; Kikuchi K; Makishima F; Isono K
    Oncol Res; 1994; 6(1):11-7. PubMed ID: 7919547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracellular ATP shows synergistic enhancement of DNA synthesis when combined with agents that are active in wound healing or as neurotransmitters.
    Wang DJ; Huang NN; Heppel LA
    Biochem Biophys Res Commun; 1990 Jan; 166(1):251-8. PubMed ID: 1967937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes.
    Creek KE; Geslani G; Batova A; Pirisi L
    Adv Exp Med Biol; 1995; 375():117-35. PubMed ID: 7645423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimizing gene expression in BPV-transformed cells: effects of cell type on enhancer/promoter interaction.
    Hurwitz DR; Hodges R; Drohan W; Sarver N
    Nucleic Acids Res; 1987 Sep; 15(17):7137-53. PubMed ID: 2821493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.
    Law MF; Lowy DR; Dvoretzky I; Howley PM
    Proc Natl Acad Sci U S A; 1981 May; 78(5):2727-31. PubMed ID: 6265905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The E5 gene of bovine papillomavirus type 1 is sufficient for complete oncogenic transformation of mouse fibroblasts.
    Bergman P; Ustav M; Sedman J; Moreno-Lopéz J; Vennström B; Pettersson U
    Oncogene; 1988 May; 2(5):453-9. PubMed ID: 2836779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes.
    Straight SW; Herman B; McCance DJ
    J Virol; 1995 May; 69(5):3185-92. PubMed ID: 7707548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Keratinocyte differentiation is associated with changes in the expression and regulation of phospholipase C isoenzymes.
    Punnonen K; Denning M; Lee E; Li L; Rhee SG; Yuspa SH
    J Invest Dermatol; 1993 Nov; 101(5):719-26. PubMed ID: 8228334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal growth factor.
    Reiss M; Sartorelli AC
    Cancer Res; 1987 Dec; 47(24 Pt 1):6705-9. PubMed ID: 2445478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation.
    Pietenpol JA; Holt JT; Stein RW; Moses HL
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3758-62. PubMed ID: 2187192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trans retinoic acid enhances the growth response of epidermal keratinocytes to epidermal growth factor and transforming growth factor beta.
    Tong PS; Horowitz NN; Wheeler LA
    J Invest Dermatol; 1990 Jan; 94(1):126-31. PubMed ID: 2295827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of two 36-kD phosphoproteins associated with altered differentiation in retrovirus-transformed Balb/MK-2 mouse keratinocytes.
    Makino JK; Weissman BE
    Pathobiology; 1991; 59(6):384-90. PubMed ID: 1930691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
    Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in EGF and TGE-beta receptor expression reflects differentiation of rat malignant oral keratinocytes.
    Game S; Stone A; Scully C; Prime S
    Biochem Soc Trans; 1991 Apr; 19(2):189S. PubMed ID: 1653725
    [No Abstract]   [Full Text] [Related]  

  • 56. [Genetic transformation of somatic cells. XI. The autonomic replication of the cloned DNA of the bovine papilloma virus in NIH/3T3 mouse fibroblasts and the changes in the growth characteristics of the transformed cells].
    Dvorianchikov GA; Pospelova TV; Tomilin NV
    Tsitologiia; 1987 Mar; 29(3):331-7. PubMed ID: 3035762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotypic transformation of primary mouse fibroblasts by BPV 1 DNA.
    Mäntyjärvi R; Sarkkinen H; Parkkinen S; Ryhänen A; Karjalainen H; Syrjänen K; Syrjänen S
    Arch Virol; 1988; 100(1-2):17-25. PubMed ID: 2839131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duplication of a viral enhancer sequence improves the stability of a vector based on BPV-1 DNA.
    Allshire RC; Bostock CJ
    Virus Res; 1986 Nov; 6(2):141-54. PubMed ID: 3026114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amplification of bovine papillomavirus DNA by N-methyl-N'-nitro-N-nitrosoguanidine, ultraviolet irradiation, or infection with herpes simplex virus.
    Schmitt J; Schlehofer JR; Mergener K; Gissmann L; zur Hausen H
    Virology; 1989 Sep; 172(1):73-81. PubMed ID: 2549724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of an immunoglobulin kappa light-chain gene in lymphoid cells using a bovine papillomavirus-1 (BPV-1) vector.
    Baker MD; Murialdo H; Shulman MJ
    Gene; 1988 Sep; 69(2):349-55. PubMed ID: 2853103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.